Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023

Rhea-AI Summary

Anika Therapeutics, Inc. (NASDAQ: ANIK) to release Q3 2023 financial results on November 2, 2023.

Positive

• Investor conference call scheduled for November 2 at 5:30 p.m. ET

Negative

• None.

BEDFORD, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its third quarter 2023 financial results after the close of the market on Thursday, November 2, 2023 and hold its investor conference call on the same day, at 5:30 p.m. ET to discuss its financial results and business highlights.

The conference call can be accessed by dialing 1-844-826-3035 (toll-free domestic) or 1-412-317-5195 (international) and providing the conference ID number 10182980. A live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the same website shortly after its conclusion.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com

FAQ

When will Anika Therapeutics release its Q3 2023 financial results?

Anika Therapeutics plans to release its Q3 2023 financial results on November 2, 2023.

What time is the investor conference call scheduled for?

The investor conference call is scheduled for 5:30 p.m. ET on November 2, 2023.

How can I access the conference call?

The conference call can be accessed by dialing 1-844-826-3035 (toll-free domestic) or 1-412-317-5195 (international) and providing the conference ID number 10182980.

Will there be a webcast of the conference call?

Yes, a live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com.

Where can I find the slide presentation accompanying the conference call?

The slide presentation can be accessed via the Anika website in the Investor Relations section.

Will the conference call be available for replay?

Yes, the call will be archived and accessible on the Anika website shortly after its conclusion.